BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27123741)

  • 1. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
    Kiserud CE; Fagerli UM; Smeland KB; Fluge Ø; Bersvendsen H; Kvaløy S; Holte H; Dahl AA
    Acta Oncol; 2016 May; 55(5):547-53. PubMed ID: 27123741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
    Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE
    BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.
    Seland M; Smeland KB; Bjøro T; Falk RS; Fosså SD; Gjesdal CG; Godang K; Holte H; Svartberg J; Syversen U; Bollerslev J; Kiserud CE
    Acta Oncol; 2017 Apr; 56(4):590-598. PubMed ID: 28077016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
    Bersvendsen HS; Haugnes HS; Fagerli UM; Fluge Ø; Holte H; Smeland KB; Wilsgaard T; Kiserud CE
    Acta Oncol; 2019 May; 58(5):690-699. PubMed ID: 30696346
    [No Abstract]   [Full Text] [Related]  

  • 5. Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy SO; Wethal T; Kiserud CE; Samersaw-Lund MB
    Acta Oncol; 2018 Jun; 57(6):773-781. PubMed ID: 29171324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early retirement and non-employment after breast cancer.
    Lindbohm ML; Kuosma E; Taskila T; Hietanen P; Carlsen K; Gudbergsson S; Gunnarsdottir H
    Psychooncology; 2014 Jun; 23(6):634-41. PubMed ID: 24347387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study.
    Murbraech K; Wethal T; Smeland KB; Holte H; Loge JH; Holte E; Rösner A; Dalen H; Kiserud CE; Aakhus S
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):230-9. PubMed ID: 26897666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.
    Dahi PB; Tamari R; Devlin SM; Maloy M; Bhatt V; Scordo M; Goldberg J; Zelenetz AD; Hamlin PA; Matasar MJ; Maragulia J; Giralt SA; Perales MA; Moskowitz CH; Sauter CS
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2004-9. PubMed ID: 25175794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].
    Trnĕný M; Vacková B; Pytlík R; Cieslar P; Válková V; Gasová Z; Kobylka P; Trnková M; Krejcová H; Klener P
    Cas Lek Cesk; 2006; 145(1):19-24. PubMed ID: 16468237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
    Simensen VC; Smeland KB; Kiserud CE; Dahl AA; Bersvendsen HS; Fluge Ø; Fagerli UM; Fosså A
    Acta Oncol; 2019 Sep; 58(9):1315-1322. PubMed ID: 31286808
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy S; Thorsen L; Arbo I; Jones LW; Aakhus S; Lund MB; Kiserud CE
    Br J Cancer; 2016 Jul; 115(2):178-87. PubMed ID: 27351215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
    Smeland K; Holte H; Fagerli UM; Bersvendsen H; Hjermstad MJ; Loge JH; Murbrach K; Linnsund MD; Fluge O; Stenehjem JS; Lund MB; Kvaloy S; Kiserud CE
    Haematologica; 2022 Nov; 107(11):2698-2707. PubMed ID: 35484681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Fayers PM; Kaasa S
    J Clin Oncol; 1999 Feb; 17(2):706-18. PubMed ID: 10080617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
    Andreadis C; Schuster SJ; Chong EA; Svoboda J; Luger SM; Porter DL; Tsai DE; Nasta SD; Elstrom RL; Goldstein SC; Downs LH; Mangan PA; Cunningham KA; Hummel KA; Gimotty PA; Siegel DL; Glatstein E; Stadtmauer EA
    Bone Marrow Transplant; 2005 Dec; 36(11):955-61. PubMed ID: 16205727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
    Baech J; Husby S; Trab T; Kragholm K; Brown P; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Severinsen MT; Grønbaek K; Larsen TS; Wästerlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
    Br J Haematol; 2024 Mar; 204(3):967-975. PubMed ID: 38155503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study.
    Mols F; Thong MS; Vreugdenhil G; van de Poll-Franse LV
    Psychooncology; 2009 Dec; 18(12):1252-60. PubMed ID: 19156675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employment and insurance outcomes and factors associated with employment among long-term thyroid cancer survivors: a population-based study from the PROFILES registry.
    Tamminga SJ; Bültmann U; Husson O; Kuijpens JL; Frings-Dresen MH; de Boer AG
    Qual Life Res; 2016 Apr; 25(4):997-1005. PubMed ID: 26395276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.